OTC · SSKN

STRATA SKIN SCIENCES Inc.

$0.01 +$0.00 (+1,150.00%) 1D Market open
Charting by TradingView

Key Metrics

$19.04K
Market cap
—
P/E · TTM
$30.70M
Revenue · TTM
−$6.26M
Net income
EPS · TTM $-1.64
Dividend yield —
Free cash flow −$4.26M
Beta · 1Y -1.18
EBITDA · TTM −$2.13M
Gross margin 58.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    The stock moved +1150.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 24
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 10
    The stock moved +39900.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 10
  • Jul 9
    From its Feb 2 high, the share price fell 100%.

    Peak close $1.28 on Feb 2; trough close $0.00 on Jul 9. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -100%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap—
Enterprise value$7.46M
Shares outstanding—
52-wk range$0.00 – $3.86
Avg volume · 20D258.0K
Net cash −$7.44M
Book value / share$0.76
ExchangeOTC
About STRATA SKIN SCIENCES Inc.
IPO date—
Employees—

STRATA SKIN SCIENCES INC

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S0.00
P/FCF—
EV/EBITDA—
EV/Sales0.24
Graham №—

Profitability

Gross 58.3%
Operating -20.4%
Net -20.4%
FCF -13.9%
ROE / ROIC -215.3% · -60.5%

Financial Health

Current ratio0.58
Quick ratio0.48
Debt / equity5.28
Debt / EBITDA -7.22
Net cash −$7.44M
Working capital−$11.14M

Cash Flow · TTM

Operating CF −$2.79M
Capex −$1.47M
Free cash flow −$4.26M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-11.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2025-09-30 · computed by TickerWolf from SEC filings